143 related articles for article (PubMed ID: 18248561)
41. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
[TBL] [Abstract][Full Text] [Related]
42. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
43. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for late relapse and death in patients with early breast cancer.
Grasic-Kuhar C; Bracko M; Zakotnik B
Neoplasma; 2008; 55(5):416-20. PubMed ID: 18665752
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution.
Orvieto E; Maiorano E; Bottiglieri L; Maisonneuve P; Rotmensz N; Galimberti V; Luini A; Brenelli F; Gatti G; Viale G
Cancer; 2008 Oct; 113(7):1511-20. PubMed ID: 18704988
[TBL] [Abstract][Full Text] [Related]
46. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.
Liu ZB; Liu GY; Yang WT; Di GH; Lu JS; Shen KW; Shen ZZ; Shao ZM; Wu J
Oncol Rep; 2008 Oct; 20(4):987-94. PubMed ID: 18813844
[TBL] [Abstract][Full Text] [Related]
47. Male breast cancer: a retrospective analysis.
Yoney A; Kucuk A; Unsal M
Cancer Radiother; 2009 Apr; 13(2):103-7. PubMed ID: 19250851
[TBL] [Abstract][Full Text] [Related]
48. Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial.
Wong JS; Taghian AG; Bellon JR; Keshaviah A; Smith BL; Winer EP; Silver B; Harris JR
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):866-70. PubMed ID: 18394815
[TBL] [Abstract][Full Text] [Related]
49. The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma.
Acs G; Paragh G; Chuang ST; Laronga C; Zhang PJ
Am J Surg Pathol; 2009 Feb; 33(2):202-10. PubMed ID: 18987549
[TBL] [Abstract][Full Text] [Related]
50. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy.
Oouchi A; Sakata K; Masuoka H; Tamakawa M; Nagakura H; Someya M; Nakata K; Asaishi K; Okazaki M; Okazaki Y; Ohmura T; Hareyama M; Hori M; Shimokawara I; Okazaki A; Watanabe Y; Yamada T; Yuyama T; Satoh T; Hirata K
Breast Cancer; 2009; 16(1):49-57. PubMed ID: 18841332
[TBL] [Abstract][Full Text] [Related]
51. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
52. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
53. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
54. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
[TBL] [Abstract][Full Text] [Related]
55. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
[TBL] [Abstract][Full Text] [Related]
56. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
Derin D; Eralp Y; Ozluk Y; Yavuz E; Guney N; Saip P; Igci A; Ozmen V; Kücücük S; Aslay I; Aydiner A; Topuz E
Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215
[TBL] [Abstract][Full Text] [Related]
57. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
58. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
59. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
[TBL] [Abstract][Full Text] [Related]
60. Histological and immunohistochemical analysis of apocrine breast carcinoma.
Matsuo K; Fukutomi T; Hasegawa T; Akashi-Tanaka S; Nanasawa T; Tsuda H
Breast Cancer; 2002; 9(1):43-9. PubMed ID: 12196721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
